Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Part of paid clinical trials in The Bronx, New York.

Sponsor
Montefiore Medical Center
Study ID
NCT00003867
Phase
PHASE1
Status
Completed

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - 120 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of irinotecan and capecitabine in treating patients who have solid tumors that have not responded to previous treatment.

Key Dates

Start date
Mar 31, 1999
Status verified
Sep 2018
Primary completion
Mar 31, 2003
Completion
Mar 31, 2003

Study Design

Enrollment
30 participants (actual)
Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
Albert Einstein Comprehensive Cancer CenterThe BronxNew York10461-

Find similar trials in The Bronx, NY

By research site
Albert Einstein Comprehensive Cancer Center· The Bronx, NY

Related Studies